By @kerrycullinan11
Publication Date: 2025-11-26 09:32:00
Artificial intelligence could compress years of drug development into months – helpful To Overcoming growing drug resistance to existing treatments for malaria and other vector-borne diseases. But scientists in low-income countries are often left behind. Jeremy Burrows, Vice President of Medicines for Malaria Venture (MMV), Head of Drug Discovery, explains how a new AI-powered open access drug discovery tool co-developed by MMV aims to level the playing field.
Given the growing role of artificial intelligence (AI) in healthcare, what specific contribution can the new technology make in the fight against malaria?
Jeremy Burrows: At MMV we focus on the mission to discover, Development and delivery of new antimalarials. Along the entire value chain, from the first idea of a possible molecule to the end,…




